- Carotid cavernous fistula: Redefining the angioarchitecture
-
Mishra K, Kumar V, V, Gandhi A, Srivastava T
- KMID: 2537320
- J Cerebrovasc Endovasc Neurosurg.
- 2022 Dec;24(4):356-365.
- doi: 10.7461/jcen.2022.E2022.05.004
Objective: Numerous classification schemes have been used for carotid cavernous fistula (CCF), each describing some aspect of the disease process but none of them provides a complete description of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Griscelli syndrome type 2: a novel mutation in RAB27A gene with different clinical features in 2 siblings: a diagnostic conundrum
-
Mishra K, Singla S, Sharma S, Saxena R, Batra VV
- KMID: 1875968
- Korean J Pediatr.
- 2014 Feb;57(2):91-95.
- doi: 10.3345/kjp.2014.57.2.91
Griscelli syndrome type 2 (GS2) is a rare autosomal recessive disease caused by mutations in the RAB27A gene. It is characterized by cutaneous hypopigmentation, immunodeficiency, and hemophagocytic lymphohistiocytosis. We describe... -
- CITED
-
- Close
- SHARE
-
- Close
- Bendamustine in combination with ifosfamide, etoposide, and vinorelbine (VIBE) is an effective salvage regimen for heavily pre-treated patients with relapsed or refractory Hodgkin lymphoma: a single-center experience
-
Prakash G, Jain A, Sahu K, Bal A, Singh C, Basher R, Singh H, Mishra K, Jandial A, Lad D, Khadwal A, Srinivasan R, Das A, Varma N, Varma S, Malhotra P
- KMID: 2520582
- Blood Res.
- 2021 Sep;56(3):134-140.
- doi: 10.5045/br.2021.2021039
Background: This study evaluated the outcomes of patients with refractory/relapsed Hodgkin lymphoma (RRHL) treated with a bendamustine-based regimen in combination with ifosfamide, etoposide, and vinorelbine (VIBE). Methods: Consecutive RRHL patients who... -
- CITED
-
- Close
- SHARE
-
- Close
